back insurance patient resources covid-19 response request records first visit info common clinical fees billing inquiries pay bill

Practice Locations

Lung Cancer Clinic - Anschutz
1665 Aurora Ct Anschutz Cancer Pavilion, Aurora, CO 80045

720-848-0300

Robert Doebele, MD, PhD

Board Certified

Schedule Appointment

Robert Doebele, MD, PhD

Physician

Board Certified

GENDER

Male

LANGUAGE

English

DEPARTMENT

Medicine

Specialty

Medical Oncology

Primary Clinic Phone

(720) 848-0300

Locations

Practice Locations

Lung Cancer Clinic - Anschutz
1665 Aurora Ct Anschutz Cancer Pavilion, Aurora, CO 80045

720-848-0300

University of Colorado Hospital (UCH)
12605 E. 16th Ave Aurora, CO 80045

720-848-0000

UCH - Cancer Center
1665 Aurora Ct Aurora, CO 80045

720-848-0300

Clinical Interest for Patients

I am interested in advancing precision medicine for lung cancer which includes identifying new gene targets. It also includes understanding mechanisms of resistance to targeted therapies. When I am not seeing patients in the clinic I run a laboratory that is developing new models for cancer research and studying mechanisms of drug resistance to targeted therapies.


Care Philosophy

Providing the most up-to-date care for lung care using precision medicine and immunotherapy approaches when appropriate.


Specialties

  • Medical Oncology ( 2007 )

Conditions & Treatments

  • Cancers

    Lung Cancer

Personal Interests

Skiing, hiking, camping, and travel.


Medical Schools

MD, University of Pennsylvania School of Medicine (2001)


Undergraduate Schools

AB, Princeton University (NJ) (1993)


Graduate Schools

PhD, University of Pennsylvania (2001)


Internships

University of Chicago Program (2002)


Residency Program

University of Chicago Program (2004)


Fellowships

University of Chicago Program (2007)

American Association for Cancer Research (AACR), Member


American Society of Clinical Oncology (ASCO), Member


International Association for the Study of Lung Cancer (IASLC), Member


Southwestern Oncology Group (SWOG), Member


University of Colorado Cancer Center, Associate Member


Grants

The role of EGFR as a mechanism of therapeutic resistance in gene fusion positive lung cancer. (2016)

SPORE In Lung Cancer (2017)


Research Interests for Patients

My research interests are primary focused on oncogene-driven cancer (ALK, ROS1, RET, NTRK1/2/3, MET, EGFR) and drug-resistance to targeted therapies. My laboratory derives new cancer models by making human cell lines and interrogating these models to understand how to better treat cancers with combination targeted therapies.

information for referring providers

Clinical Interests for Referring Providers

Precision medicine for lung cancer and other malignancies with expertise in oncogene-driven lung cancer harboring ALK, ROS1, EGFR, HER2, BRAF, RET, MET and other oncogenes. Thoracic Malignancies (Non-small Cell Lung Cancer, Small Cell Lung Cancer, Malignant Mesothelioma, Malignant Thymoma/Thymic Carcinoma)

Research Interest for Referring Providers

My research interests are primary focused on oncogene-driven cancer (ALK, ROS1, RET, NTRK1/2/3, MET, EGFR) and drug-resistance to targeted therapies. My laboratory derives new cancer models by making human cell lines and interrogating these models to understand how to better treat cancers with combination targeted therapies.


Referral Contact Phone: (720) 848-0300